알츠하이머병

Access to amyloid PET changes the diagnosis and care of many patients in whom the diagnosis of...

Seasonal fluctuations in the symptoms of Alzheimer’s and Parkinson’s Diseases may...

For people with mental illness or disabling neurological conditions, restrictions imposed to...

Altering the intestinal flora can influence host immunity, neuro-inflammation, and the deposition...

Novel tracers for PET imaging and the increasing range of CSF and plasma assays for amyloid-β and...

Populations most vulnerable to Alzheimer’s disease (AD) need to be better represented in AD...

Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are...

The complexities of preventing and managing infection are multiplied in people living with dementia...

We are in the age of big data. The number of biomedical variables that can be measured has exploded...

Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and...

Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how...

Far from running dry, the pipeline is well provided with agents in development for Alzheimer’...